Oxford Biomedica stock price trades in a volatile fashion as COVID-19 vaccine testing is paused

Shares of Oxford Biomedica (LON: OXB) have been trading in a volatile manner in the past two days after its partner AstraZeneca said it had to pause COVID-19 vaccine trial testing. Fundamental analysis: AZN eliminated from a race? A major drugmaker AstraZeneca, and Oxford University, reported that their coronavirus vaccine trial has been paused, raising concerns among investors over how the halt might affect the supply deal between the two companies.  The trial was put on hold after a British participant experienced a suspected adverse reaction. AstraZeneca said they paused testing on a voluntary basis and will work with the